Patient-Reported Outcomes as Interradiographic Predictors of Response in Non-Small Cell Lung Cancer.

ABSTRACT:

Purpose

Minimally invasive biomarkers have been used as important indicators of treatment response and progression in cancers such as prostate and ovarian. Unfortunately, all biomarkers are not prognostic in all cancer types and are often not routinely collected. Patient-reported outcomes (PRO) provide a non-obtrusive, personalized measure of a patient's quality of life and symptomatology, reported directly from the patient, and are increasingly collected as part of routine care. Previous literature has shown correlations between specific PROs (i.e., insomnia, fatigue) and overall survival. Although promising, these studies often only consider single time points and ignore patient-specific dynamic changes in individual PROs, which might be early predictors of treatment response or

SUBMITTER: Bhatt AS 

PROVIDER: S-EPMC10425729 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature